SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 201 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,288 | -62.6% | 53,831 | -19.0% | 0.01% | -65.0% |
Q2 2023 | $86,432 | -15.0% | 66,486 | +15.0% | 0.02% | -23.1% |
Q1 2023 | $101,725 | -45.1% | 57,798 | -2.0% | 0.03% | -56.7% |
Q4 2022 | $185,270 | -49.0% | 59,003 | -20.3% | 0.06% | -50.8% |
Q3 2022 | $363,000 | +17.9% | 74,051 | -0.4% | 0.12% | +22.0% |
Q2 2022 | $308,000 | -28.4% | 74,378 | +0.5% | 0.10% | -20.6% |
Q1 2022 | $430,000 | -23.5% | 73,978 | -1.2% | 0.13% | -22.2% |
Q4 2021 | $562,000 | -18.8% | 74,898 | -2.5% | 0.16% | -28.3% |
Q3 2021 | $692,000 | -25.6% | 76,837 | -1.1% | 0.23% | -27.1% |
Q2 2021 | $930,000 | -2.3% | 77,680 | +2.3% | 0.31% | -18.0% |
Q1 2021 | $952,000 | -14.3% | 75,945 | +6.7% | 0.38% | -30.3% |
Q4 2020 | $1,111,000 | +90.9% | 71,173 | +15.5% | 0.54% | +57.1% |
Q3 2020 | $582,000 | +47.0% | 61,633 | +39.6% | 0.34% | +42.0% |
Q2 2020 | $396,000 | +47.2% | 44,155 | +4.4% | 0.24% | +22.7% |
Q1 2020 | $269,000 | +15.9% | 42,275 | +52.6% | 0.20% | +59.7% |
Q4 2019 | $232,000 | +10.0% | 27,697 | +18.7% | 0.12% | +5.1% |
Q3 2019 | $211,000 | – | 23,327 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |